Stockreport

Veracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25

Veracyte, Inc.  (VCYT) 
Last veracyte, inc. earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that multiple abstracts will be pr [Read more]